The temporary TRIPS waiver would allow countries and manufacturers to directly access and share technologies to produce vaccines and therapeutics without causing trade sanctions or international disputes.
Senior health officials have urged the public to realise that the Covid-19 pandemic is not over yet and the community as a whole must follow Covid-appropriate behaviour